Search Results

125 Implant Seeds are indicated for permanent interstitial treatment of selected localized tumors such as head and neck, lung, pancreas and early stage prostate. 125 Implant Seeds may be used in superficial, intraabdominal or intra-thoracic locations. 125 Implant Seeds may also be used in the treatment of residual tumors following completion of external beam radiation therapy and for other recurrent tumors.

Not Found

The provided FDA 510(k) clearance letter and Indications for Use statement do not contain the kind of detailed information about acceptance criteria, study design, and performance metrics typically expected for AI/ML-driven medical devices.

This document is for a conventional medical device (I-125 Implant Seeds) that received 510(k) clearance in 1999. The clearance process for such devices largely relied on demonstrating substantial equivalence to a predicate device, often without the need for extensive clinical studies with specific performance metrics and ground truth establishment in the way AI/ML devices require.

Therefore, I cannot provide the requested information based on the given text. The information points you've requested (such as sample size, data provenance, number of experts for ground truth, adjudication methods, MRMC studies, standalone performance, training set details) are characteristic of the evidence required for AI/ML device submissions, which is not applicable to this 1999 clearance for a radioactive seed.

Ask a specific question about this device